A study published online in The Lancet Oncology showed a score integrating clinical and biological markers which could help foresee the chance of mortality in patients with malignant pleural effusion and their probability of benefiting from pleurodesis.
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.